AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

NewMed Energy

Regulatory Filings Feb 15, 2023

7125_rns_2023-02-15_b692e6f7-4e73-4082-ae08-0c4dbc5a71f9.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 0243Q

NewMed Energy

15 February 2023

February 15, 2023

Mutual Termination of the Transaction for a Business Combination with Capricorn Energy PLC ("Capricorn")

Further to NewMed Energy - Limited Partnership's ("NewMed") press release of January 15, 2023, with respect to a business combination transaction with Capricorn Energy PLC ("Capricorn" and the "Transaction", respectively), NewMed notes that, following the recent developments at Capricorn, including the fundamental change in the composition of Capricorn's board and senior management, that NewMed and Capricorn have mutually agreed to terminate the Transaction with immediate effect.

Ends

NewMed Energy +972 (0) 9 9712424
Yossi Abu
Guil Bashan
Nadav Perry
J.P. Morgan (Financial Adviser to NewMed) +44 (0)20 7742 4000
Yoni Hornik
Daniele Apa
Jamie Riddell
Camarco +44 (0)20 3757 4980
Billy Clegg
Owen Roberts
Violet Wilson

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRANKPBQKBKDPBD

Talk to a Data Expert

Have a question? We'll get back to you promptly.